Table 1.
Clinical characteristics of the patients
| Liver disease (n = 176) | HCC (n = 369) | P value | |
|---|---|---|---|
| Age (y) | 46.34 ± 11.71 | 56.91 ± 10.04 | < 0.001 |
| Gender (M/F) | 124/52 | 318/51 | < 0.001 |
| Neutrophils (× 109/L) | 5.705 (2.97–58.20) | 0.674 (0.57–0.78) | < 0.001 |
| Lymphocytes (× 109/L) | 3.01 (1.65–30.85) | 0.209 (0.12–0.295) | < 0.001 |
| NLR | 1.851 (1.43–2.53) | 3.23 (1.91–6.62) | < 0.001 |
| ALT (IU/mL) | 38.5 (26.00–66.50) | 38.9 (23.75–73.93) | 0.739 |
| AST (IU/mL) | 29 (21.00–52.00) | 44 (29.78–85.65) | < 0.001 |
| AFP (ng/mL) | 3.67 (2.43–10.36) | 41.16 (5.59–1030.03) | < 0.001 |
HCC, hepatocellular carcinoma; M, male; F, female; NLR, neutrophil-granulocyte ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AFP, alpha-fetoprotein
Data are presented as mean ± standard derivation for age, actual values for gender, and median (interquartile range, Q25-Q75) for other parameters
Comparisons between two groups were performed using t test for age, chi-square test for gender, or Wilcoxon test for other parameters